CPR Therapeutics Inc. (CPR-T), a start-up medical device company, announced today that it has received a National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I award for its project “A MULTIMODAL INTEGRATED SYSTEM FOR IMPROVED CARDIOPULMONARY RESUSCITATION” in the amount of $256K. The award is for a collaboration with The Johns Hopkins Hospital in Baltimore, MD.
CPR Therapeutics is developing multimodal cardiopulmonary resuscitation (CPR), a more effective form of automated mechanical CPR. Sudden cardiac arrest is the leading cause of death in western countries and there are currently no devices more effective than manual CPR. Intact survival after sudden cardiac arrest is below 10% in most communities.
Norman Paradis MD, CPR Therapeutics Founder and CEO said “We are excited to have received this validation of our efforts from one of the most prestigious scientific organizations in the world. The NSF has an extraordinary record of identifying and supporting innovations that eventually reach the bedside and improve patient outcomes.”
Henry Halperin MD, the company’s Chief Scientific Officer and a Professor of Cardiology at Johns Hopkins said “this support will significantly advance our ongoing preclinical development of multimodal CPR. In particular, it will allow us to focus on optimizing the synergies between the multiple pump mechanisms and refine the synchronization with electrical countershock.”
Studies supported by the award will begin immediately and will accelerate the company’s plan to commercialize an in-hospital version of its Vest-CPR System™.
